Skip to main content

Advertisement

Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Clinical Phytoscience Cover Image
  • Original contribution
  • Open Access

Evaluation of aphrodisiac activity of ethanol extract of Ganoderma lucidum in male Wistar rats

Clinical PhytoscienceInternational Journal of Phytomedicine and Phytotherapy20184:26

https://doi.org/10.1186/s40816-018-0086-7

©  The Author(s). 2018

  • Received: 27 February 2018
  • Accepted: 21 August 2018
  • Published:

Abstract

Background

Ganoderma lucidum was traditionally used to manage male sexual dysfunction. This study was designed to investigate and establish the traditional aphrodisiac potential of the herb.

Methods

Aphrodisiac potential was evaluated following the oral administration of two different doses (150 and 300 mg/kg) of ethanol extract of Ganoderma lucidum. Sildenafil citrate (Viagra) and distilled water were used as positive and negative controls respectively. Mounting, intromission and ejaculation frequencies, mating performance, and orientation activities towards females, towards the environment, and towards self were observed. Serum testosterone levels were also evaluated.

Results

The results of the study show that the extract has significantly increased the mounting behavior and mating performance of the rats. There was also significant increase in the number of intromissions and ejaculations. The rats treated with extract were more interested in female rats as indicated by significant increase in the number of anogenital sniffing and climbing. Serum testosterone levels were also significantly increased in the treatment groups.

Conclusion

Ethanol extract of Ganoderma lucidum possesses aphrodisiac activity in male Wistar rats. The lower dose of 150 mg/kg was more effective in terms of aphrodisiac potential of the extract.

Keywords

  • Ganoderma lucidum
  • Sildenafil citrate
  • Aphrodisiac
  • Testosterone

Background

Male infertility is due to any problem in the male reproductive system, including: decreased sexual desire, barrenness, premature ejaculation and erectile dysfunction [1]. Sex is a highly important aspect of living organisms which plays a key role in their survival. Substances that increase the sexual desire are called aphrodisiac agents. The term aphrodisiac is derived from “Aphrodite”, that means the “Greek goddess of sexuality and love” [2]. In allopathic medicine, there are various drugs which can increase the sexual craving in both male and female, although these drugs have numerous harmful effects [3]. Phosphodiesterase type 5 inhibitors, like tadalafil (Cialis) and sildenafil (Viagra) are the most commonly used aphrodisiac agents, but these drugs cause dizziness, headache, visual disturbance, pulse irregularities, dyspepsia, priapism, diarrhoea and flushing [4].

Mushrooms have been one of the major sources of several medicinal products. There are around 10,000 varieties of mushrooms, out of which 2000 have nonpoisonous effects and around 300 of them have shown important medicinal effects [5]. Studies show that mushroom extracts are advantageous for the human body, as they have shown several pharmacological activities such as anti-bacterial, anti-inflammatory, anti-viral and anti-hyperglycemic activity [6].

Ganoderma lucidum (reishi) is denoted as a sacred mushroom in Chinese culture [7]. These days, reishi has gained a great value in medicinal product development because of its medicinal properties [8]. Ganoderma lucidum is not only used to treat common health problems, [9] but it has also been used as an anti-cancer agent alone or with western chemotherapy medications [10].

From the fruiting bodies, spores, and mycelia of reishi, various types of bioactive compounds have been identified which commonly consist of proteins, peptides, triterpenoids, sterols, polysaccharides, steroids, nucleotides and trace elements [11, 12]. Ganoderma lucidum has shown various pharmacological activities which include antiviral (anti-HIV), hepatoprotective, anti-ulcer antibacterial, anti-tumour, anti-inflammatory, radio-protective, age promoting, analgesic, hypolipidemic, sleep promoting, cytotoxic, chemopreventive, antifibrotic, antiatherosclerotic, antidiabetic, radical scavenging and antioxidative properties [8, 11, 13–16]. In this study, we have evaluated the potential aphrodisiac activity of ethanol extract of Ganoderma lucidum (GLE) in male Wistar rats.

Methods

Drugs and chemicals

Ganoderma lucidum extract composed of cracked spores and fruiting bodies, branded ReishiMaxGLpTM, was procured from Pharmanex Inc. (United States of America). Sildenafil was purchased from Pfizer, USA, while progesterone and estradiol benzoate were procured from Sigma Aldrich, Pakistan.

Animals

Healthy adult rats (Wistar strain) bearing weight of 150–200 g were purchased from the animal house of Dow University of Health Sciences, Pakistan. Polypropylene cages have been used for keeping the animals under controlled conditions at room temperature (25–30 °C) with light-dark cycle of 12\12 h. Standard diet and water ad libitum were given to the rats. Handling of the animals was done according to the requirements mentioned in “Guidelines for the care and use of laboratory animals 8th edition” [17]. Prior approval of the ethical review committee of Ziauddin University was taken before starting this research study.

Animal groups

Male rats were divided into four groups (n = 6):

  • Group I: Control group, given distilled water (10 ml/kg) orally for 40 days.

  • Group II: Treatment group, given extract (150 mg/kg) for 40 days.

  • Group III: Treatment group, given extract (300 mg/kg) for 40 days.

  • Group IV: Standard drug group, given sildenafil citrate (5 mg/kg) for 40 days.

Preparation of male rats

Sexual behaviour training was given to male rats for 10 days. The animal that did not show any sexual interest was replaced by another sexually active rat [18, 19].

Preparation of female rats

Oestrus (heat) was developed artificially in female rats by giving progesterone (0.5 mg / 100 g body weight) and estradiol benzoate (10 microgram/100 g body weight) over the subcutaneous route sequentially before mating. Before conducting the experiment the receptivity of female rats was ensured [18, 19].

A number of parameters such as mounting behaviour, mating performance, orientation activities of male rats towards the surrounding, towards female and towards themselves were observed for the assessment of aphrodisiac activity of the extract.

Mounting behaviour test

The climbing property of male rats onto the female rats is known as “Mounting”. To assess the number of mounts, the mounting behaviour test was performed. Males, treated with the extract, were paired with non-oestrus female rats. The behaviour of the animals was noted for 3 h on the 10th, 20th and 40th day of the study. Male rats were placed individually in each cage. After 15 min of acclimation, non-oestrus female was introduced into each cage and number of mounts were noted at the beginning of 1st hour for next 15 min. Every female was then given a resting period of 105 min by pulling it from each cage. The females were again introduced into the cages and the number of mounts were again noted for 15 min before the end of 3rd hour of the test. The test was performed at room temperature of 25–27 °C between 9 a.m. to 12 p.m. [18, 19].

Determination of mating performance

In this test every male rat was settled separately in a glass cage. After the acclimation period of 15 min, five oestrus females were admitted into each cage and they cohabited overnight. For the detection of any sperms in females, microscopic investigation of the vaginal smear of every female rat was performed. Sperm positive females were noted in every group [18, 19].

Test for libido

In this test sexually experienced male rats demonstrating vigorous sexual performance were selected. Mounting Frequency (MF) was observed in these rats in the evening of 10th, 20th and 40th day. Before initiating the observation, the sheath of the penis was retracted to expose the penis of rats and xylocaine 5% ointment (AstraZeneca Pharma) was applied at the interval of 5, 15 and 30 min. Each male rat was allocated separately in a cage and female rats were admitted in the similar cage. The total number of intromissions and ejaculations were observed [20].

Determination of the orientation activities of male rats

In this test the behavioural activities of the male rats, towards the surrounding, towards themselves and towards females were examined. The rats were observed and the number of climbings, genital groomings, lickings and anogenital sniffings were counted for one hour [21].

Preparation of serum for testosterone analysis

The blood was collected via cardiac puncture using chloroform anaesthesia. Using sterilized syringe, 5 ml of blood was collected in appropriately labelled blank tubes containing no anti-coagulant. The tubes were given 5 to 10 min for coagulation before they were subjected to centrifugation. The needles were changed for every single animal. After coagulation these tubes were centrifuged at 3000 rpm for 10 min. The supernatant formed after centrifugation was sucked and collected in a clean, empty tube for testosterone assay [22].

Testosterone analysis

Quantitative determination of total testosterone was done by the competitive imunoenzymatic colorimetric method mentioned in the manufacturer’s test procedure (Diametra testosterone ELISA kit). The absorbance was noted at 420 nm against a reference wavelength of 620–630 nm.

Statistical analysis

One-way ANOVA followed by Tukey’s test was used for analysing the data. Data were expressed as mean ± standard error of mean. A statistical level of 0.05 or less was accepted as significant.

Results

In mounting behavior test, during 1st and 3rd hour of the test, GLE showed extremely significant effect at both doses viz. 150 mg/kg and 300 mg/kg when compared with control group. However, 150 mg/kg GLE was noted as the most effective aphrodisiac dose (Figs. 1 and 2).
Fig. 1
Fig. 1

Effect of Ganoderma lucidum on mounting behavior (1st hour) in male rats. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Fig. 2
Fig. 2

Effect of Ganoderma lucidum on mounting behavior (3rd hour) in male rats. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

An extremely significant difference was recorded in mating performance test. The results show that there were more sperm positive females in GLE (150 mg/kg and 300 mg/kg) groups in comparison to normal control group on 10th, 20th and 40th day of the study. Our results suggest that 150 mg/kg dose is more effective than 300 mg/kg dose in terms of mating performance test. The results of 150 mg/kg are comparable to sildenafil citrate, positive control (Fig. 3).
Fig. 3
Fig. 3

Effect of Ganoderma lucidum on mating performance test in male rats. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

The results of libido test show that the number of intromissions and ejaculations in GLE groups was significantly high when compared with control group. We observed very promising results of GLE in terms of the number of intromissions and ejaculations. The effect of GLE (150 mg/kg) was greater than sildenafil citrate in libido test (Figs. 4 and 5).
Fig. 4
Fig. 4

Effect of Ganoderma lucidum on number of intromissions in male rats. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Fig. 5
Fig. 5

Effect of Ganoderma lucidum on number of ejaculations in male rats. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

The results of orientation activities show significant increase in the activities of male rats in terms of anogenital sniffing, licking, climbing and genital grooming. There was extremely significant increase in the orientation activities of GLE (150 mg/kg) when compared with control group (Figs. 6, 7, 8 and 9).
Fig. 6
Fig. 6

Effect of Ganoderma lucidum on anogenital sniffing. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Fig. 7
Fig. 7

Effect of Ganoderma lucidum on lickings. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Fig. 8
Fig. 8

Effect of Ganoderma lucidum on climbing. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Fig. 9
Fig. 9

Effect of Ganoderma lucidum on genital grooming. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Ganoderma lucidum significantly increased the serum testosterone levels in male rats when compared with control group (Fig. 10).
Fig. 10
Fig. 10

Effect of Ganoderma lucidum on testosterone levels. Animals per group (n) = 6. The values are mean ± S.E.M.; ap < 0.05; bp < 0.01; cp < 0.001 when compared with control group. (One-way ANOVA followed by Tukey’s post hoc test)

Discussion

Mounting and intromission frequencies are the important indicators of libido. Mounting frequency shows the increase in sexual desire and increase in intromission frequency reflects the ability of penile erection, penile introduction, and the responses which trigger ejaculation [23, 24].

In this study, the results show that Ganoderma lucidum increases the number of mounts which represents that continuous administration of the extract significantly increases the sexual desire when compared with control group and sildenafil citrate 5 mg/kg group.

The ability of doing sex is not only dependent on sexual desire but it also depends on erectile function. If an individual is suffering from erectile dysfunction, it can cause a major barrier in sexual performance even in presence of strong sexual desire. Sexual performance depends on neurovascular occasions by means of hemodynamic mechanism of penile erection [25]. Therefore, the increase in the intromission and ejaculation frequencies with the administration of GLE indicates that extract significantly increases the sexual performance of male rats. The increase in the intromission frequency proposed that adequate penile erection was accomplished by this extract [26]. Hence, GLE may be investigated for the treatment of erectile dysfunction.

Moreover, there were more sperm positive females in the mating performance test which also supports the aphrodisiac potential of the extract. The similarity in the results of mating performance test of ethanol extract of Ganoderma lucidum and sildenafil citrate reveals identical aphrodisiac activity of both agents. However, in mating performance test a reverse inhibition of sexual performance was seen at the dose of 300 mg/kg of the extract on 10th and 40th day of the study which may be because of sedation in the form of negative sexual interest among the rats. The same result of sexual inhibition was shown with the findings of Afolayan and Yakubu and Ratnasooriya and Dharmasiri which supports the results of our study [24, 26].

The orientation activity of the male rat is one of the very important parameters to evaluate the aphrodisiac activity in rodents. Results of orientation activity tests of male rats showed that GLE, at the dose of 150 mg/kg; significantly increased the attention of male rats towards female rats when compared with control group and sildenafil citrate 5 mg/kg group.

Many research studies have reported that increase in the sexual desire may be due to an increment in the levels of serum testosterone and anterior pituitary hormones. These hormones are considered as major stimulators of neurotransmitters such as dopamine which helps in conducting the actions related to sexual behavior and copulation [24, 27, 28]. Testosterone is an important steroidal hormone secreted from the leydig cells of the testes [29]. It has been reported that the use of testosterone significantly increases the sexual desire and function. Testosterone also increases the climax of sexual excitement and ejaculation [30, 31].

The results of our study show that Ganoderma lucidum significantly elevated the testosterone level in male rats. This increase in the testosterone level is the most important parameter to establish the aphrodisiac potential of the GLE.

Certain bioactive compounds play the major role in enhancing testosterone levels endogenously and for boosting the sexual behavior in males. These compounds work by special mechanism which includes: steroids by promoting androgen production [32, 33] alkaloids through widening the blood vessels in the reproductive organs, saponins through stimulating gonadal tissue and CNS by means of NO based mechanism [34] flavonoids by increasing testosterone synthesis or by preventing its metabolic deterioration [35, 36] Steroids are one of the dominant components of Ganoderma lucidum [11]. Thus, the enhancement in sexual activity exhibited in the present study may be due to the presence of steroids in GLE.

Conclusion

According to Solomon P. Wasser [37], Ganoderma lucidum was traditionally used to manage male sexual dysfunction. This study was designed to investigate and establish the traditional aphrodisiac potential of the herb. The results of this study show that the parameters of mounting behavior test, mating performance test, orientation activities and the test for libido were increased in the animals treated with GLE when compared with the animals treated with distilled water. The increase in above mentioned parameters may due to enhancing effect of GLE on the testosterone levels. Hence, we conclude that GLE may be a new promising aphrodisiac agent, which can be used to promote the sexual performance of many troubled men.

Abbreviations

ANOVA: 

Analysis of variance

CNS: 

Central nervous system

ELISA: 

Enzyme linked immunosorbent assay

GLE: 

Ganoderma lucidum extract

kg: 

Kilogram

MF: 

Mounting frequency

mg: 

Milligram

NO: 

Nitric oxide

rpm: 

Rotations per minute

SEM: 

Standard error of mean

Declarations

Funding

This research study was not granted any specific fund.

Authors’ contributions

Study design and supervision, analysis of data, graphical representation, interpretation of results and drafting manuscript were done by MA. Sample collection and laboratory experiments were performed by HA. Both authors read and approved the final manuscript.

Ethics approval

Handling of the animals was done according to the requirements mentioned in “Guidelines for the care and use of laboratory animals 8th edition”. Prior approval of the ethical review committee of Ziauddin University was taken before starting this research study.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi, 75600, Pakistan
(2)
Department of Pharmacology, Faculty of Pharmacy, University of Sindh, Jamshoro, 76080, Pakistan

References

  1. Kothari P. Common sexual problems - solutions. 2nd ed. New Delhi: UBS Publishers Distributors (P), Limited; 1994.Google Scholar
  2. Kulkarni SK, Reddy DS. Pharmacotherapy of male erectile dysfunction with sildenafil. Indian J Pharmacol. 1998;30(6):367–8.Google Scholar
  3. Aagaard L, Hansen E. Side effects reported by European consumers for medications for erectile dysfunction. J Res Pharm Pract. 2013;2(2):93.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Hammoud MA, Jin F, Lea T, Maher L, Grierson J, Prestage G. Off-label use of phosphodiesterase type 5 inhibitor erectile dysfunction medication to enhance sex among gay and bisexual men in Australia: results from the FLUX study. J Sex Med. 2017;14(6):774–84.View ArticleGoogle Scholar
  5. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Critc Rev Immunol. 1999;19(1):1–32.Google Scholar
  6. De Silva DD, Rapior S, Fons F, Bahkali AH, Hyde KD. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action. Fungal Divers. 2012;55(1):1–35.View ArticleGoogle Scholar
  7. Babu PD, Subhasree RS. The sacred mushroom “Reishi”-a review. American-Euras. J Bot. 2008;1(3):107–10.Google Scholar
  8. Chang ST, Buswell JA. Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)− a mushrooming medicinal mushroom. Int J Med Mushrooms. 1999;1(2):139–46.View ArticleGoogle Scholar
  9. Shiao MS. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. The Chem Record. 2003;3(3):172–80.View ArticleGoogle Scholar
  10. Gordan JD, Chay WY, Kelley RK, Ko AH, Choo SP, Venook AP. And what other medications are you taking? J Clin Oncol. 2011;29(11):e288–91.View ArticleGoogle Scholar
  11. McKenna D, Jones K, Hughes K. Botanical Medicines. New York: Routledge; 2011.Google Scholar
  12. Gao Y, Zhou S, Chen G, Dai X, Ye J. A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. Extract (Ganopofy) in patients with advanced cancer. Int J Med Mushrooms. 2002;4(3):1–8.View ArticleGoogle Scholar
  13. Zhao XL, Campos AR. Insulin signalling in mushroom body neurons regulates feeding behaviour in Drosophila larvae. J Exp Biol. 2012;215(15):2696–702.View ArticleGoogle Scholar
  14. Batra P, Sharma AK, Khajuria R. Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. Int J Med Mushrooms. 2013;15(2):127–43.View ArticleGoogle Scholar
  15. Yuen JW, Gohel MD, Ng CF. Synergistic cytotoxic effects of Ganoderma lucidum and bacillus calmette guérin on premalignant urothelial HUC-PC cells and its regulation on proinflammatory cytokine secretion. Evid Based Complement Alternat Med. 2012;2012:1–9.View ArticleGoogle Scholar
  16. Li F, Zhang Y, Zhong Z. Antihyperglycemic effect of Ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci. 2011;12(9):6135–45.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Garber J, Barbee W, Bielitzki J, Clayton L, Donovan J, Kohn D, Lipman N, Locke P, Melcher J, Quimby F, Turner P, Wood G, Würbel H. Guidelines for care and use of laboratory animals. 8 Ed. Washington, D.C: The National Academies Press; 2011.Google Scholar
  18. Aslam M, Sial AA. Effect of hydroalcoholic extract of Cydonia oblonga miller (quince) on sexual behaviour of Wistar rats. Adv Pharmacol Sci. 2014;2014:1–6.View ArticleGoogle Scholar
  19. Ahmad S, Latif A, Qasmi IA. Aphrodisiac activity of 50% ethanolic extracts of Myristica fragrans Houtt. (nutmeg) and Syzygium aromaticum (L) Merr. & Perry. (clove) in male mice: a comparative study. BMC Complement Altern Med. 2003;3(1):1–6.View ArticleGoogle Scholar
  20. Zade V, Dabhadkar D, Thakare V, Pare S. Evaluation of potential aphrodisiac activity of Moringa oleifera seed in male albino rats. Int J Pharm Pharm Sci. 2013;5(4):683–9.Google Scholar
  21. Pande M, Pathak A. Aphrodisiac activity of roots of Mimosa pudica Linn. Ethanolic extract in mice. Int J Pharm Sci Nanotechnol. 2009;2(1):477–86.Google Scholar
  22. Yakubu MT, Akanji MA, Oladiji AT. Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian J Androl. 2005;7(4):399–404.View ArticleGoogle Scholar
  23. Yakubu MT, Akanji MA. Effect of aqueous extract of Massularia acuminata stem on sexual behaviour of male Wistar rats. Ev-Based Compl and Alter Med. 2011;2011:1–10.View ArticleGoogle Scholar
  24. Ratnasooriya WD, Dharmasiri MG. Effects of Terminalia catappa seeds on sexual behaviour and fertility of male rats. Asian J Androl. 2000;2(3):213–20.Google Scholar
  25. Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011;63(4):811–59.View ArticleGoogle Scholar
  26. Afolayan AJ, Yakubu MT. Effect of Bulbine natalensis baker stem extract on the functional indices and histology of the liver and kidney of male Wistar rats. J Med Food. 2009;12(4):814–20.View ArticleGoogle Scholar
  27. Giuliano F, Allard J. Dopamine and male sexual function. Europ Urol. 2001;40(6):601–8.View ArticleGoogle Scholar
  28. Bahmanpour S, Talaei T, Vojdani Z, Panjehshahin MR, Poostpasand A, Zareei S, Ghaeminia M. Effect of Phoenix dactylifera pollen on sperm parameters and reproductive system of adult male rats. Iran J Med Sci. 2015;31(4):208–12.Google Scholar
  29. Cao L, Leers-Sucheta S, Azhar S. Aging alters the functional expression of enzymatic and non-enzymatic anti-oxidant defense systems in testicular rat Leydig cells. J Steroid Biochem Mol Biol. 2004;88(1):61–7.View ArticleGoogle Scholar
  30. Aversa A, Fabbri A. New oral agents for erectile dysfunction: what is changing in our practice. Asian J Androl. 2001;3(3):175–9.Google Scholar
  31. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metabol. 1996;81(8):2854–64.Google Scholar
  32. Drewes SE, George J, Khan F. Recent findings on natural products with erectile-dysfunction activity. Phytochemistry. 2003;62(7):1019–25.View ArticleGoogle Scholar
  33. Gauthaman K, Ganesan AP. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction–an evaluation using primates, rabbit and rat. Phytomed. 2008;15(1–2):44–54.View ArticleGoogle Scholar
  34. Murphy LL, Ginseng LEETJ. Sex behavior, and nitric oxide. Annal New York Acad Sci. 2002;962(1):372–7.View ArticleGoogle Scholar
  35. Ratnasooriya WD, Fernando TS. Effect of black tea brew of Camellia sinensis on sexual competence of male rats. J Ethnopharmacol. 2008;118(3):373–7.View ArticleGoogle Scholar
  36. Yang NY, Kaphle K, Wang PH, Jong DS, Wu LS, Lin JH. Effects of aqueous extracts of" betel quid" and its constituents on testosterone production by dispersed mouse interstitial cells. American J Chinese Med. 2004;32(5):705–15.View ArticleGoogle Scholar
  37. Wasser SP. Reishi or Ling Zhi (Ganoderma lucidum). Encycl Diet Suppl. 2005;1:603–22.Google Scholar

Copyright

© The Author(s). 2018

Advertisement